Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-18-024025
Filing Date
2018-09-07
Accepted
2018-09-07 17:47:56
Documents
1
Period of Report
2018-09-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4028
  Complete submission text file 0000899243-18-024025.txt   5369
Mailing Address 281 ALBANY STREET CAMBRIDGE MA 02139
Business Address 281 ALBANY STREET CAMBRIDGE MA 02139 617-995-0900
AILERON THERAPEUTICS INC (Issuer) CIK: 0001420565 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AILERON THERAPEUTICS, INC. 281 ALBANY STREET CAMBRIDGE MA 02139
Business Address
Aivado Manuel (Reporting) CIK: 0001709603 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38130 | Film No.: 181060989